Table 4.
This Table Summarizes Differences Between Three Stone Phenotypes.
| ICSF | BRSF | HASF | |
|---|---|---|---|
| pH | 6 ±0.01 | 6.3 ±0.05* | 6.3 ±0.04* |
| SS CaP | 1.54 ±0.04 | 2.3 ±0.1* | 2 ±0.1* |
| SS CaOx | 9.7 ±0.2 | 10.1 ±0.6 | 9 ±0.5 |
| Ca mg/d | 237 ±3 | 297 ±12* | 271 ±10* |
| RP % SURFACE | 8 | 6 | 0.8 |
| DEPOSITS/MM^3 | 0 | 4 | 12 |
| DEPOSIT MM^2 | 0 | 1.6 | 0.4 |
| STONES ON RP | 10/patient | 3/25 patients | 6/11 patients |
| DILATION | 0.2 | 0.17 | 0.8 |
| INJURY | 0.18 | 0.37 | 0.58 |
| TIF OR G >1 | 2/30 6.7% | 13/21 62% | 4/11 36.4% |
| BR IN STONES | 0 | >0 | 0 |
SS CaP, calcium phosphate supersaturation; SS CaOx, calcium oxalate supersaturation; Ca mg/d, urinary calcium in milligrams per day. RP, Randall’s plaque; TIF, tubule-interstitial fibrosis, G, glomerular; BR, brushite.